Xenofon Baraliakos - Concepedia

Author

Xenofon Baraliakos

Also Known As

Baraliakos X, Baraliakos, X, Baraliakos, X., Baraliakos, Xenofon, Diana Vossen, I. Andreica, Michael Hofer, Nele Herregods, X Baraliakos, X. Baraliakos

Publications

31.5K

Citations

H-Index

Concepts

All Affiliations

Rheumazentrum Ruhrgebiet Ruhr University Bochum Charité - Universitätsmedizin Berlin Leiden University Medical Center German Rheumatism Research Centre

About

Xenofon Baraliakos is an author at Rheumazentrum Ruhrgebiet specializing in medicine, rheumatology, and orthopaedics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	36	2.2K
2	Health Sciences	8	8	249
3	Engineering	1	1	22
4	Allergy	1	1	14
5	Anatomy	1	1	106

Xenofon Baraliakos

220

Publications

21.3K

Citations

H-Index

Page 1

	Year	Citations
The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis Joachim Sieper, Martín Rudwaleit, Xenofon Baraliakos, Annals of the Rheumatic Diseases	2009	1.6K
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis Dominique Baeten, Joachim Sieper, Jürgen Braun, New England Journal of Medicine	2015	973
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update Laure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer, Annals of the Rheumatic Diseases	2020	917
Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group Martín Rudwaleit, Anne Grethe Jurik, Kay‐Geert Hermann, Annals of the Rheumatic Diseases	2009	867
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update Sofía Ramiro, Elena Nikiphorou, Alexandre Sepriano, Annals of the Rheumatic Diseases	2022	808
The early disease stage in axial spondylarthritis: Results from the german spondyloarthritis inception cohort Martín Rudwaleit, Hildrun Haibel, Xenofon Baraliakos, Arthritis & Rheumatism	2009	713
Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force Josef S Smolen, Monika Schöls, Jürgen Braun, Annals of the Rheumatic Diseases	2017	662
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial Dominique Baeten, Xenofon Baraliakos, Jürgen Braun, The Lancet InflammationRheumatologyRheumatoid DisorderAutoimmune DiseaseMedicine	2013	585
Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis Désirée van der Heijde, Robert Landewé, Xenofon Baraliakos, Arthritis & Rheumatism	2008	512
Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: Evaluation of a new scoring system Jürgen Braun, Xenofon Baraliakos, W. Golder, Arthritis & Rheumatism	2003	398

Page 1